| Literature DB >> 35836691 |
Tan Shot Yen1,2, Min Kyaw Htet1,3,4, Widjaja Lukito5, Saptawati Bardosono2, Rianto Setiabudy6, Endang S Basuki7, Aris Wibudi8, Drajat Martianto9, Imam Subekti10, Umi Fahmida1.
Abstract
Dietary patterns high in fibre and green leafy vegetables have shown an inverse association with lower risks of type 2 diabetes mellitus and improved glycaemic control. The study aimed to investigate the effects of increased vegetable intake and conventional diabetes diet on glycaemic control among type 2 diabetic patients. White-collar workers from one telecommunication company with type 2 diabetes were assigned to two treatment groups by cluster randomisation. Individuals with known type 2 diabetes and poor glycaemic control (HbA1c ≥8 g%) were eligible and a total of 84 subjects were recruited. Subjects in the intervention group (n 41) were offered to attend seminars and intensive coaching weekly to encourage them to increase raw vegetable intake. The control group (n 40) followed the conventional diet according to the guidelines of the Indonesian Society of Endocrinology. Glycated haemoglobin (HbA1c), plasma lipids, blood pressure, vegetable intake and anthropometric measurements were assessed at baseline and end line of 12 weeks intervention. A regression analysis was conducted using differences in HbA1C between baseline and 12 weeks as the dependent variable. Student's t test was conducted for the changes of biochemical indicators from baseline to end line during the period of 12 weeks intervention. Glycaemic control improved in the intervention group and mean HbA1C, fasting blood glucose and post-prandial blood glucose in the intervention group decreased significantly along with body weight, waist circumference and total cholesterol. The finding suggested that the intervention which emphasised raw vegetable intake contributed to improved glycaemic control among Indonesian adults with type 2 diabetes mellitus.Entities:
Keywords: Diabetes mellitus; Glycaemic control; Indonesia; Raw vegetables; White-collar workers
Mesh:
Substances:
Year: 2022 PMID: 35836691 PMCID: PMC9241062 DOI: 10.1017/jns.2022.41
Source DB: PubMed Journal: J Nutr Sci ISSN: 2048-6790
Fig. 1.Participant flowchart.
Background characteristics of respondents
| Characteristics | Intervention (40) | Control (41) | |||
|---|---|---|---|---|---|
| % | % | ||||
| Age group (year) | |||||
| <40 | 7⋅5 | 3 | 2⋅4 | 1 | 0⋅534 |
| 40–50 | 35⋅0 | 14 | 39⋅0 | 16 | |
| >50 | 57⋅5 | 23 | 58⋅5 | 24 | |
| Gender | |||||
| Male | 80⋅0 | 32 | 85⋅4 | 35 | 0⋅532 |
| Female | 20⋅0 | 8 | 14⋅6 | 6 | |
| Ethnicity | |||||
| Javanese | 67⋅5 | 27 | 68⋅3 | 28 | 0⋅728 |
| Sundanese | 20⋅0 | 8 | 14⋅6 | 6 | |
| Others | 12⋅5 | 5 | 17⋅1 | 7 | |
| Marital Status | |||||
| Single | 2⋅5 | 1 | 2⋅4 | 1 | 0⋅856 |
| Married | 95⋅0 | 38 | 92⋅7 | 38 | |
| Others | 2⋅5 | 1 | 4⋅9 | 2 | |
| Education status | |||||
| High School | 50⋅0 | 20 | 46⋅3 | 19 | 0⋅379 |
| Diploma | 17⋅5 | 7 | 7⋅3 | 3 | |
| Graduate | 30⋅0 | 12 | 39⋅0 | 16 | |
| Postgraduate | 2⋅5 | 1 | 7⋅3 | 3 | |
| Income per month | |||||
| <2 million Rp | 10⋅0 | 4 | 2⋅4 | 1 | 0⋅527 |
| 2 to <5 million Rp | 20⋅0 | 8 | 17⋅1 | 7 | |
| 5 to <10 million Rp | 50⋅0 | 20 | 56⋅1 | 23 | |
| ≥10 million Rp | 20⋅0 | 8 | 24⋅4 | 10 | |
| Smoking status | |||||
| I do not smoke | 45⋅0 | 18 | 43⋅9 | 18 | 0⋅603 |
| Current smoker | 30⋅0 | 12 | 22⋅0 | 9 | |
| Former smoker | 25⋅0 | 10 | 34⋅1 | 14 | |
| Family History of DM | |||||
| Yes | 50⋅0 | 20 | 58⋅5 | 24 | 0⋅595 |
| No | 50⋅0 | 20 | 41⋅5 | 17 | |
Chi-square test, significance at P < 0⋅05.
Energy, macronutrient and vegetable intakes between the intervention and control groups at baseline and end line of 12 weeks intervention
| Intervention | Control | ||||||
|---|---|---|---|---|---|---|---|
| 25th | Median | 75th | 25th | Median | 75th | ||
| Vegetable intake (g/d) | |||||||
| Baseline | 10 | 17 | 41 | 12 | 27 | 77 | 0⋅238 |
| End line | 513 | 787 | 902 | 36 | 103 | 413 | <0⋅001 |
| Energy intake (kcal/d) | |||||||
| Baseline | 1376 | 1543 | 1867 | 1198 | 1598 | 1934 | 0⋅991 |
| End line | 1074 | 1267 | 1446 | 1265 | 1576 | 1762 | 0⋅048 |
| Carbohydrate (g/d) | |||||||
| Baseline | 187 | 240 | 290 | 191 | 237 | 276 | 0⋅811 |
| End line | 82 | 97 | 181 | 155 | 204 | 246 | 0⋅005 |
| Protein intake (g/d) | |||||||
| Baseline | 54 | 68 | 84 | 43 | 69 | 93 | 0⋅794 |
| End line | 66 | 91 | 103 | 61 | 69 | 83 | 0⋅195 |
| Fat intake (g/d) | |||||||
| Baseline | 28 | 46 | 60 | 22 | 38 | 54 | 0⋅501 |
| End line | 30 | 48 | 62 | 37 | 45 | 56 | 0⋅938 |
| Carbohydrate (% Energy) | |||||||
| Baseline | 47⋅2 | 53⋅9 | 64⋅5 | 53⋅9 | 62⋅9 | 66⋅6 | 0⋅204 |
| End line | 28⋅4 | 40⋅1 | 51⋅1 | 42⋅3 | 54⋅9 | 58⋅5 | 0⋅004 |
| Protein (% Energy) | |||||||
| Baseline | 12⋅8 | 17⋅3 | 19⋅8 | 13⋅8 | 16⋅4 | 20⋅1 | 0⋅937 |
| End line | 21⋅3 | 26⋅3 | 31⋅1 | 16⋅7 | 18⋅1 | 22⋅8 | 0⋅005 |
| Fat (% Energy) | |||||||
| Baseline | 16⋅4 | 25⋅8 | 30⋅6 | 16⋅0 | 21⋅7 | 27⋅4 | 0⋅296 |
| End line | 23⋅7 | 31⋅1 | 43⋅4 | 23⋅4 | 28⋅0 | 32⋅0 | 0⋅200 |
Vegetable intake: N 40 for intervention, N 41 for control at baseline and end line.
Energy and nutrient intakes; energy distribution: N 21 for intervention, N 23 for control at baseline, N 16 for intervention, N 34 for control at end line, Somersd, significance at P < 0⋅05.
Indicators of glycaemic control and lipid profile between the intervention and control groups at baseline and end line of the 12 weeks intervention
| Variables | Intervention (40) | Control (41) | |||
|---|---|---|---|---|---|
| Mean | Mean | ||||
| Haemoglobin (g/dl) | |||||
| Baseline | 13⋅3 | 1⋅8 | 13⋅8 | 1⋅6 | 0⋅173 |
| End line | 13⋅5 | 1⋅8 | 14⋅2 | 1⋅7 | 0⋅048 |
| Difference | 0⋅2 | 1⋅2 | 0⋅4 | 1⋅7 | 0⋅475 |
| HbA1C (%) | |||||
| Baseline | 10⋅5 | 1⋅2 | 10⋅1 | 1⋅2 | 0⋅154 |
| End line | 7⋅4 | 1⋅2 | 7⋅8 | 1⋅2 | 0⋅211 |
| Difference | −3⋅1 | 1⋅7 | −2⋅3 | 1⋅0 | 0⋅009 |
| FBG (mg/dl) | |||||
| Baseline | 204⋅2 | 1⋅4 | 187⋅6 | 1⋅3 | 0⋅184 |
| End line | 131⋅5 | 1⋅3 | 138⋅3 | 1⋅3 | 0⋅413 |
| Difference | −76⋅5 | 62⋅9 | −50⋅2 | 43⋅4 | 0⋅031 |
| Post-prandial Glucose (mg/dl) | |||||
| Baseline | 307⋅3 | 92⋅6 | 280⋅5 | 75⋅7 | 0⋅163 |
| End line | 139⋅6 | 1⋅4 | 165⋅0 | 1⋅5 | 0⋅042 |
| Difference | −156⋅3 | 93⋅3 | −101⋅9 | 78⋅0 | 0⋅006 |
| Total Cholesterol (mg/dl) | |||||
| Baseline | 217⋅9 | 1⋅2 | 206⋅2 | 1⋅2 | 0⋅239 |
| End line | 198⋅1 | 1⋅2 | 204⋅7 | 1⋅2 | 0⋅448 |
| Difference | −21⋅0 | 46⋅5 | −1⋅9 | 36⋅1 | 0⋅042 |
| Triacylglycerol (mg/dl) | |||||
| Baseline | 159⋅7 | 1⋅7 | 154⋅7 | 1⋅5 | 0⋅768 |
| End line | 111⋅3 | 1⋅6 | 129⋅2 | 1⋅5 | 0⋅124 |
| Difference | −59⋅3 | 96⋅9 | −29⋅3 | 42⋅9 | 0⋅074 |
| LDL (mg/dl) | |||||
| Baseline | 144⋅2 | 39⋅9 | 133⋅8 | 39⋅9 | 0⋅242 |
| End line | 128⋅7 | 1⋅3 | 131⋅2 | 1⋅3 | 0⋅754 |
| Difference | −11⋅0 | 41⋅7 | 2⋅4 | 34⋅6 | 0⋅119 |
| HDL (mg/dl) | |||||
| Baseline | 42⋅1 | 1⋅3 | 43⋅3 | 1⋅2 | 0⋅564 |
| End line | 43⋅8 | 1⋅3 | 45⋅0 | 1⋅2 | 0⋅597 |
| Difference | 1⋅9 | 10⋅1 | 1⋅7 | 4⋅0 | 0⋅933 |
| Apoprotein B (mg/dl) | |||||
| Baseline | 121⋅5 | 1⋅3 | 114⋅3 | 1⋅3 | 0⋅276 |
| End line | 117⋅4 | 1⋅2 | 120⋅9 | 1⋅3 | 0⋅550 |
| Difference | −5⋅7 | 31⋅5 | 6⋅6 | 23⋅8 | 0⋅051 |
Geometric mean and sd, independent sample T-test significance at P < 0⋅05.
Regression analysis on mean difference in HbA1C from baseline to 12 weeks after intervention
| Unadjusted | Adjusted model | |||
|---|---|---|---|---|
| Coefficient (95 % CI) | Coefficient (95 % CI) | |||
| Age (year) | −0⋅04 (−0⋅1, 0⋅03) | 0⋅30 | ||
| Gender | ||||
| Female | −0⋅7 (−1⋅5, 0⋅2) | 0⋅11 | −0⋅3 (−1⋅1, 0⋅5) | 0⋅44 |
| Education | ||||
| High school | ||||
| Diploma | 0⋅2 (−0⋅9, 1⋅2) | 0⋅76 | 0⋅4 (−0⋅5, 1⋅3) | 0⋅34 |
| Graduate and higher | 0⋅2 (−0⋅5, 0⋅9) | 0⋅64 | 0⋅1 (−0⋅4, 0⋅7) | 0⋅63 |
| Income (million Rp) | ||||
| <5 | ||||
| 5 to <10 | 0⋅4 (−0⋅3, 1⋅2) | 0⋅28 | ||
| ≥10 | 0⋅6 (−0⋅3, 1⋅5) | 0⋅21 | ||
| Smoking | ||||
| None smoker | ||||
| Current smoker | 0⋅7 (−0⋅9, 1⋅5) | 0⋅08 | 0⋅5 (−0⋅2, 1⋅3) | 0⋅18 |
| Ex-smoker | 0⋅4 (−0⋅4, 1⋅1) | 0⋅34 | −0⋅3 (−1, 0⋅4) | 0⋅44 |
| Family history of DM | ||||
| No | −0⋅6 (−1⋅3, −0⋅03) | 0⋅04 | −0⋅1 (−0⋅7, 0⋅5) | 0⋅78 |
| Anthropometry | ||||
| Weight at baseline | 0⋅01(−0⋅01, 0⋅04) | 0⋅23 | ||
| Waist circumference at baseline | 0⋅01(−0⋅02, 0⋅04) | 0⋅60 | ||
| BMI at baseline | 0 (−0⋅07, 0⋅08) | 0⋅91 | ||
| Baseline Biochemical indicator | ||||
| HbA1C | −0⋅5 (−0⋅7, −0⋅3) | <0⋅001 | −0⋅5 (−0⋅7, −0⋅3) | <0⋅001 |
| FBG | −0⋅02 (−0⋅01, 0⋅02) | 0⋅28 | ||
| PPG | 0 (−0⋅01, 0⋅01) | 0⋅20 | ||
| Insulin use (baseline) | ||||
| Yes | 1⋅1 (0⋅2, 2⋅1) | 0⋅02 | 0⋅7 (−0⋅2, 1��5) | 0⋅11 |
| Treatment | ||||
| Intervention | −0⋅83 (−1⋅4, −0⋅2) | 0⋅01 | −0⋅7 (−1⋅2, −0⋅1) | 0⋅02 |
Adjusted R-square: 0⋅407.
P < 0⋅001.